Abeona Therapeutics Files Investor Presentation for H.C. Wainwright 2026

What Happened Abeona Therapeutics Inc. (ABEO) filed a Current Report on Form 8-K on September 15, 2026 (Item 7.01) to furnish an updated investor presentation it expects to use, in whole or in part, at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The presentation is included as Exhibit 99.1 to the filing and is incorporated by reference into the report. This disclosure was supplied pursuant to Regulation FD.

Key Details

• Filing date: September 15, 2026 (Form 8-K; Item 7.01 — Regulation FD Disclosure).
• Event: H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026.
• Exhibit: Presentation titled “H.C. Wainwright 28th Annual Global Investment Conference,” dated September 15, 2026 (Exhibit 99.1) furnished with the 8-K.
• No earnings, executive changes, or other financial results were reported in this filing.

Why It Matters This 8-K provides investors with the company’s latest presentation materials that Abeona plans to use at a public investor conference, offering a direct source for the company’s current messaging on strategy, programs, or pipeline. Because it was furnished under Regulation FD, the presentation is intended to ensure broad, public disclosure rather than confidential communication. The filing itself does not announce new financial results or corporate actions; investors should review the attached Exhibit 99.1 for details and await any subsequent filings for material updates.